Author: Bolger, Jarlath C.; Donlon, Noel E.; Butt, Waqas; Neary, Colm; Al Azzawi, Mohammed; Brett, Orla; King, Sinead; Downey, Eithne; Arumugasamy, Mayilone; Murphy, Thomas; Robb, William B.; Collins, Chris G.; Carroll, Paul A.; Donohoe, Claire L.; Ravi, Narayanasamy; Reynolds, John V.
Title: Successful maintenance of process and outcomes for oesophageal cancer surgery in Ireland during the first wave of the COVID-19 pandemic Cord-id: d7qx9qvl Document date: 2021_3_16
ID: d7qx9qvl
Snippet: INTRODUCTION: The emergence of the novel coronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the coronavirus disease COVID-19 has impacted enormously on non-COVID-19-related hospital care. Curtailment of intensive care unit (ICU) access threatens complex surgery, particularly impacting on outcomes for time-sensitive cancer surgery. Oesophageal cancer surgery is a good example. This study explored the impact of the pandemic on process and short-term surgical outcomes, com
Document: INTRODUCTION: The emergence of the novel coronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the coronavirus disease COVID-19 has impacted enormously on non-COVID-19-related hospital care. Curtailment of intensive care unit (ICU) access threatens complex surgery, particularly impacting on outcomes for time-sensitive cancer surgery. Oesophageal cancer surgery is a good example. This study explored the impact of the pandemic on process and short-term surgical outcomes, comparing the first wave of the pandemic from April to June in 2020 with the same period in 2019. METHODS: Data from all four Irish oesophageal cancer centres were reviewed. All patients undergoing resection for oesophageal malignancy from 1 April to 30 June inclusive in 2020 and 2019 were included. Patient, disease, and peri-operative outcomes (including COVID-19 infection) were compared. RESULTS: In 2020, 45 patients underwent oesophagectomy, and 53 in the equivalent period in 2019. There were no differences in patient demographics, co-morbidities, or use of neoadjuvant therapy. The median time to surgery from neoadjuvant therapy was 8 weeks in both 2020 and 2019. There were no significant differences in operative interventions between the two time periods. There was no difference in operative morbidity in 2020 and 2019 (28% vs 40%, p = 0.28). There was no in-hospital mortality in either period. No patient contracted COVID-19 in the perioperative period. CONCLUSIONS: Continuing surgical resection for oesophageal cancer was feasible and safe during the COVID-19 pandemic in Ireland. The national response to this threat was therefore successful by these criteria in the curative management of oesophageal cancer.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and admission prior: 1, 2, 3, 4, 5, 6
- acute ards respiratory distress syndrome and low risk hospital: 1, 2
- acute ards respiratory distress syndrome develop and adjuvant therapy: 1, 2
- acute case and adjuvant therapy: 1, 2, 3
- acute case and admission prior: 1, 2, 3, 4, 5, 6, 7
- acute case and locally advanced: 1, 2
- acute respiratory and adjuvant therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and admission prior: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and locally advanced: 1, 2
- acute respiratory and low risk hospital: 1, 2
- adjuvant therapy and admission prior: 1
- adjuvant therapy and locally advanced: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- adjuvant therapy and locally advanced disease: 1, 2, 3, 4, 5, 6, 7
Co phrase search for related documents, hyperlinks ordered by date